AU7608174A - Metabolites 27481/f-1 & f-2 - Google Patents

Metabolites 27481/f-1 & f-2

Info

Publication number
AU7608174A
AU7608174A AU76081/74A AU7608174A AU7608174A AU 7608174 A AU7608174 A AU 7608174A AU 76081/74 A AU76081/74 A AU 76081/74A AU 7608174 A AU7608174 A AU 7608174A AU 7608174 A AU7608174 A AU 7608174A
Authority
AU
Australia
Prior art keywords
metabolites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU76081/74A
Other versions
AU500889B2 (en
Inventor
E. & Ruegger A Harri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25713544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU7608174(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CH1711173A external-priority patent/CH589716A5/en
Priority claimed from CH1404374A external-priority patent/CH603790A5/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7608174A publication Critical patent/AU7608174A/en
Application granted granted Critical
Publication of AU500889B2 publication Critical patent/AU500889B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/06—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/885—Trichoderma

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU76081/74A 1973-12-06 1974-12-04 Metabolites 27481/f-1 & f-2 Expired AU500889B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CHCH17111/73 1973-12-06
CH1711173A CH589716A5 (en) 1973-12-06 1973-12-06 Antibiotics S 7481-F-1 and 2 - prepd. from new strains of Cylindrocarbon or Trichoderma esp. useful as immunosuppressant
CH1404374A CH603790A5 (en) 1974-10-21 1974-10-21 Antibiotics S 7481-F-1 and 2
CHCH14043/74 1974-10-21

Publications (2)

Publication Number Publication Date
AU7608174A true AU7608174A (en) 1976-06-10
AU500889B2 AU500889B2 (en) 1979-06-07

Family

ID=25713544

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76081/74A Expired AU500889B2 (en) 1973-12-06 1974-12-04 Metabolites 27481/f-1 & f-2

Country Status (19)

Country Link
JP (1) JPS5615235B2 (en)
AU (1) AU500889B2 (en)
CA (1) CA1030469A (en)
DD (1) DD115695A5 (en)
DE (2) DE2455859C2 (en)
DK (1) DK136780B (en)
ES (1) ES432559A1 (en)
FI (2) FI52851C (en)
FR (1) FR2253531B1 (en)
GB (1) GB1491509A (en)
HK (1) HK53880A (en)
IE (1) IE40549B1 (en)
IL (1) IL46180A (en)
MY (1) MY8100203A (en)
NL (1) NL179220C (en)
NO (1) NO744292L (en)
NZ (1) NZ176117A (en)
PH (1) PH13773A (en)
SE (1) SE423720B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (en) * 1975-11-04 1979-12-28 Sandoz Ag
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
FI65914C (en) * 1978-03-07 1984-08-10 Sandoz Ag FRAMEWORK FOR PHARMACEUTICAL COMPOSITION OF CYCLOSPORINE A
SE448386B (en) * 1978-10-18 1987-02-16 Sandoz Ag NEW CYCLOSPORIN DERIVATIVES, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
IE54936B1 (en) * 1980-02-14 1990-03-28 Sandoz Ltd A method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
US4396542A (en) 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
DE3260468D1 (en) 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins
JPS59129920U (en) * 1983-02-16 1984-08-31 日立造船株式会社 Opening/closing device for bypass valve with gate
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
FI111730B (en) 1990-11-02 2003-09-15 Novartis Ag A process for the preparation of a non-immunosuppressive cyclosporin
JP3099365B2 (en) * 1991-01-25 2000-10-16 藤沢薬品工業株式会社 Method for producing cyclosporin A and / or C
KR100304324B1 (en) * 1994-10-13 2001-11-22 김용규 Method for manufacturing cyclosporine a
DK0789580T3 (en) 1994-11-03 2002-09-09 Novartis Ag New Formulations of Cyclosporin for Oral Administration with Simple Composition and High Bioavailability, and Methods for their Preparation
US6423233B1 (en) 2000-08-15 2002-07-23 Biogal Gyogyszergyar Rt. Purification process
AU2004222306A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
EP1804823A4 (en) 2004-09-29 2010-06-09 Amr Technology Inc Novel cyclosporin analogues and their pharmaceutical uses
JP2008514701A (en) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド Cyclosporine alkyne analogs and their pharmaceutical use
JP2008515886A (en) 2004-10-06 2008-05-15 エーエムアール テクノロジー インコーポレイテッド Cyclosporine alkynes and their usefulness as medical drugs
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
EP2151450A1 (en) 2008-07-29 2010-02-10 Sandoz AG Method for processing microbiologically produced cyclic oligopeptides

Also Published As

Publication number Publication date
DK136780B (en) 1977-11-21
DK136780C (en) 1978-05-01
FI771201A (en) 1977-04-15
AU500889B2 (en) 1979-06-07
CA1030469A (en) 1978-05-02
FI343474A (en) 1975-06-07
SE7415027L (en) 1975-06-09
DD115695A5 (en) 1975-10-12
IE40549B1 (en) 1979-06-20
DK617074A (en) 1975-07-28
DE2455859C2 (en) 1983-12-15
GB1491509A (en) 1977-11-09
DE2463138C2 (en) 1984-07-05
IE40549L (en) 1975-06-06
IL46180A (en) 1978-07-31
IL46180A0 (en) 1975-03-13
DE2455859A1 (en) 1975-06-12
FI54606C (en) 1979-01-10
HK53880A (en) 1980-10-03
FR2253531A1 (en) 1975-07-04
JPS5089598A (en) 1975-07-18
FR2253531B1 (en) 1978-07-21
FI54606B (en) 1978-09-29
FI52851B (en) 1977-08-31
JPS5615235B2 (en) 1981-04-09
ES432559A1 (en) 1977-03-01
NZ176117A (en) 1981-05-01
NL7415682A (en) 1975-06-10
MY8100203A (en) 1981-12-31
NL179220C (en) 1986-08-01
NO744292L (en) 1975-06-30
PH13773A (en) 1980-09-23
NL179220B (en) 1986-03-03
FI52851C (en) 1977-12-12
SE423720B (en) 1982-05-24

Similar Documents

Publication Publication Date Title
AU474137B2 (en) Auto-refractometer
AU500889B2 (en) Metabolites 27481/f-1 & f-2
AU468964B2 (en) Melik
CA1019217A (en) Osteotome
CA1023739A (en) N-(3-hydroxyaryl-propyl)-imides
CA1016963A (en) Alumina-chrome refractory
CA986736A (en) Foundations
CA994351A (en) Tetrahydronaphthyloxy-amines and related compounds
AU472276B2 (en) Camparator circuitry
AU476397B2 (en) A-cycloalkylbenzyl lactamimides
CA999964A (en) Loudspeaker
AU476505B2 (en) Alkylbenxyl lactamimides
CA1016181A (en) Substituted pyrrolidinemethanols
AU472907B2 (en) Firecheck
CA1034943A (en) Substituted phenylglycylcephalosporins
CA1011527A (en) Anchor assembly
CA1022943A (en) Substituted ureido-s-triazines
CA1026331A (en) Substituted indolobenzazepines
AU473700B2 (en) New thiadiazolylimidazolidinones
AU476386B2 (en) Dibenzocycloheptenyl lactamimides
CA998297A (en) Anchors
AU471241B2 (en) Benzothiazolylureas
AU477508B2 (en) Anchor
CA969746A (en) Pledgets
AU481104B2 (en) Substituted benzoylacrylanilides